Do you need to talk to a Depakote lawsuit attorney? Contact Williams Hart today - 800-761-3187.

Whistleblower lawsuit filed over Abbott’s Depakote ‘off-labeling’

A whisteblower lawsuit filed against Abbott Laboratories for allegedly telling employees to market epilepsy drugs for unapproved uses.

According to Abbott Labs employees, the corporate message and federal law states that the company can only market drugs for approved use. But this message was different during training because trainees were allegedly told that they should market Depakote, an epilepsy medication, to treat agitation associated with dementia.

Although doctors are allowed to prescribe drugs for what is known as ‘off-label’ use, drug manufacturers are not allowed to market the drug for uses that have not been approved by the Food and Drug Administration. The company announced last month that they put aside nearly $1.5 billion in order to settle this Depakote issue.

Depakote has also faced legal issues after is was discovered that if taken during pregnancy, children face a higher risk of developing a birth defect. if this has happened to you, contact the Depakote lawsuit lawyers of Williams Hart today by calling 800-761-3187.

Tagged , | Leave a comment

Contact Williams Hart

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.





home  |  about us  |  attorneys  |  depakote  |  birth defects  |  other side effects  |  faqs  |  articles  |  legal resources  |  contact us  |  press  |  blog  |  Log in
Copyright ©2007-2010 Williams Hart. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Hart's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-761-3187